Article Details
Retrieved on: 2025-01-27 16:18:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Can-Fite BioPharma Ltd. announced that its lead drug candidate Namodenoson was granted a patent for its use as an anti-obesity drug by the US ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here